SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001424884-14-000092
Filing Date
2014-08-18
Accepted
2014-08-18 15:40:34
Documents
9
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 1108880
2 exhibit31-1.htm EX-31.1 14739
3 exhibit32-1.htm EX-32.1 6453
  Complete submission text file 0001424884-14-000092.txt   4295465

Data Files

Seq Description Document Type Size
4 tpiv-20140630.xml EX-101.INS 699056
5 tpiv-20140630.xsd EX-101.SCH 26490
6 tpiv-20140630_cal.xml EX-101.CAL 45223
7 tpiv-20140630_def.xml EX-101.DEF 44302
8 tpiv-20140630_lab.xml EX-101.LAB 149554
9 tpiv-20140630_pre.xml EX-101.PRE 117061
Mailing Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6
Business Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6 604-264-8274
TAPIMMUNE INC (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: NV | Fiscal Year End: 0220
Type: 10-Q | Act: 34 | File No.: 000-27239 | Film No.: 141048988
SIC: 2834 Pharmaceutical Preparations